• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

122
16
12
10
9

COUNTRY

4
4
3
3
2

PRICE

91
121
261
410

PUBLISHED

0
11
70
410

PRODUCT TYPE

405
4
1

Immune Disorders

More than 150 primary immunodeficiency diseases (PIDs) have been identified, a number that does not include acquired immunodeficiencies. Examples of immune disorders include Type 1 diabetes, rheumatoid arthritis, allergies, Crohn’s Disease, and HIV, which infects over 0.5% of the world’s population.

In the reports and subscriptions listed under Research and Markets’ category you will find pipeline assessments of drugs and therapeutics, market forecasts, investment and growth opportunities, and much more. Also explored in-depth is the key role of immune response and pharmaceuticals in transplant medicine, with reviews of clinical trials, market trends and major companies in the areas of lung transplants, liver transplants, transplant inflammation/rejection, etc.

Key players profiled include Abbott Laboratories, Pfizer, Johnson & Johnson, Biogen Idec, Amgen, Bayer AG, Sanofi, and more. Show Less
Read more

PRODUCT TITLE

Kidney Transplantation Global Clinical Trials Review, H1, 2012

Kidney Transplantation Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Kidney Transplantation Global Clinical Trials Review, H1, 2012" provides data on the Kidney...

February 2012
FROM

Transplantation Global Clinical Trials Review, H1, 2012

Transplantation Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Transplantation Global Clinical Trials Review, H1, 2012" provides data on the Transplantation clinical...

February 2012
FROM

Immunomodulators Market to 2017 - Immunosuppressant Antibodies to Replace Antimetabolites as the Highest Value Sector by 2017

Leading business intelligence provider GBI Research has released its latest research report, “Immunomodulators Market to 2017 - Immunosuppressant Antibodies to Replace Antimetabolites as the Highest...

February 2012
FROM
02 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities 02 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities - Product Thumbnail Image

02 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 43 emerging medical technology companies that have been identified by LSI's in-house research team in February 2012 All companies include technology, market(s), key executive,...

February 2012
FROM
Triple Analysis: Lymphoma, Apoptosis and Angiogenesis Triple Analysis: Lymphoma, Apoptosis and Angiogenesis - Product Thumbnail Image

Triple Analysis: Lymphoma, Apoptosis and Angiogenesis

This triple analysis focuses on cancer drug development strategies in Lymphoma and by the two mechanism/target/effect areas of Apoptosis and Angiogenesis. Each of these three individual parts is evaluated...

January 2012
Triple Analysis: Lung Cancer, Apoptosis and Angiogenesis Triple Analysis: Lung Cancer, Apoptosis and Angiogenesis - Product Thumbnail Image

Triple Analysis: Lung Cancer, Apoptosis and Angiogenesis

This triple analysis focuses on cancer drug development strategies in Lung Cancer and by the two mechanism/target/effect areas of Apoptosis and Angiogenesis. Each of these three individual parts is...

January 2012

Ankylosing Spondylitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Ankylosing Spondylitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Ankylosing Spondylitis Therapeutics...

January 2012
FROM
Angioedema - Pipeline Review, H1 2012 Angioedema - Pipeline Review, H1 2012 - Product Thumbnail Image

Angioedema - Pipeline Review, H1 2012

Angioedema – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Angioedema - Pipeline Review, H1 2012', provides an overview of the Angioedema therapeutic pipeline. This report provides information...

January 2012
FROM
Lung Transplantation - Pipeline Review, H1 2012 Lung Transplantation - Pipeline Review, H1 2012 - Product Thumbnail Image

Lung Transplantation - Pipeline Review, H1 2012

Lung Transplantation – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Lung Transplantation - Pipeline Review, H1 2012', provides an overview of the Lung Transplantation therapeutic pipeline....

January 2012
FROM

Liver Transplantation Global Clinical Trials Review, H1, 2012

Liver Transplantation Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Liver Transplantation Global Clinical Trials Review, H2, 2011" provides data on the Liver...

January 2012
FROM

Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2012

Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H2, 2011" provides...

January 2012
FROM
01 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities 01 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities - Product Thumbnail Image

01 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 47 emerging medical technology companies that have been identified by LSI's in-house research team in January 2012 All companies include technology, market(s), key executive,...

January 2012
FROM
Behcet's Disease - Pipeline Review, H2 2011 Behcet's Disease - Pipeline Review, H2 2011 - Product Thumbnail Image

Behcet's Disease - Pipeline Review, H2 2011

Behcet's Disease – Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Behcet's Disease - Pipeline Review, H2 2011', provides an overview of the Behcet's Disease therapeutic pipeline. This...

December 2011
FROM
Crohn's Disease (CD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Crohn's Disease (CD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 - Product Thumbnail Image

Crohn's Disease (CD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Crohn’s Disease (CD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, “Crohn’s Disease (CD) Therapeutics...

December 2011
FROM
Triple Analysis: Lung Cancer, Lymphoma and Apoptosis Triple Analysis: Lung Cancer, Lymphoma and Apoptosis - Product Thumbnail Image

Triple Analysis: Lung Cancer, Lymphoma and Apoptosis

This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Lymphoma and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated...

December 2011
FROM

Systemic Lupus Erythematosus: Visual Guide for Clinicians

An instructive, highly-illustrated guide to the investigation, diagnosis and management of systemic lupus erythematosus (SLE) and the related condition of Sjögren's syndrome Appropriate investigations...

December 2011
FROM

Angioedema Global Clinical Trials Review, H2, 2011

Angioedema Global Clinical Trials Review, H2, 2011 Summary GlobalData's clinical trial report, “Angioedema Global Clinical Trials Review, H2, 2011" provides data on the Angioedema clinical trial scenario....

November 2011
FROM

Birch Pollen Allergy - Pipeline Review, H2 2011

Birch Pollen Allergy - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Birch Pollen Allergy - Pipeline Review, H2 2011', provides an overview of the Birch Pollen Allergy therapeutic pipeline....

November 2011
FROM

Sjogren's Syndrome - Pipeline Review, H2 2011

Sjogren's Syndrome - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Sjogren's Syndrome - Pipeline Review, H2 2011', provides an overview of the Sjogren's Syndrome therapeutic pipeline....

November 2011
FROM

Auto Inflammatory Disease - Pipeline Review, H2 2011

Auto Inflammatory Disease - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Auto Inflammatory Disease - Pipeline Review, H2 2011', provides an overview of the Auto Inflammatory Disease...

November 2011
FROM
Loading Indicator

Our Clients

Our clients' logos